Clearmind Medicine Inc (CMND)

Currency in USD
1.740
+0.010(+0.58%)
Closed·
1.7400.000(0.00%)
·
CMND is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.7401.835
52 wk Range
1.430524.000
Key Statistics
Prev. Close
1.73
Open
1.74
Day's Range
1.74-1.835
52 wk Range
1.43-524
Volume
45.73K
Average Volume (3m)
1.89M
1-Year Change
-99.565%
Book Value / Share
11.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CMND Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Clearmind Medicine Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Jun 15, 2026
EPS / Forecast
-6.78 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CMND Income Statement

Compare CMND to Peers and Sector

Metrics to compare
CMND
Peers
Sector
Relationship
P/E Ratio
−0.3x−2.3x−0.3x
PEG Ratio
0.000.010.00
Price/Book
0.2x1.3x2.6x
Price / LTM Sales
-1.4x3.1x
Upside (Analyst Target)
-87.2%47.6%
Fair Value Upside
Unlock3.8%5.6%Unlock

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.29K0.09%2.47K
Other Institutional Investors
82.97K5.59%158.47K
Public Companies & Retail Investors
1.40M94.33%2.68M
Total
1.49M100.00%2.84M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hudson River Trading LLC5.48%81,353155
XTX Markets Limited0.15%2,1694

People Also Watch

1.270
LASE
-1.55%
0.7281
HUBC
-1.18%
7.5100
ASTC
-0.66%
7.1900
INHD
-2.71%
2.63
TDIC
+3.14%

FAQ

What Is the Clearmind Medicine (CMND) Stock Price Today?

The Clearmind Medicine stock price today is 1.740 USD.

What Stock Exchange Does Clearmind Medicine Trade On?

Clearmind Medicine is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Clearmind Medicine?

The stock symbol for Clearmind Medicine is "CMND."

What Is the Clearmind Medicine Market Cap?

As of today, Clearmind Medicine market cap is 2.570M USD.

What Is Clearmind Medicine's Earnings Per Share (TTM)?

The Clearmind Medicine EPS (TTM) is -71.491.

From a Technical Analysis Perspective, Is CMND a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Clearmind Medicine Stock Split?

Clearmind Medicine has split 3 times.

What is the current trading status of Clearmind Medicine (CMND)?

As of Aug 21, 2026, Clearmind Medicine (CMND) is trading at a price of 1.740 USD, with a previous close of 1.730 USD. The stock has fluctuated within a day range of 1.740 USD to 1.835 USD, while its 52-week range spans from 1.430 USD to 524.000 USD.

What Is the CMND Premarket Price?

CMND's last pre-market stock price is 1.802 USD. The pre-market share volume is 4,990.000, and the stock has decreased by 0.072, or 4.160%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.